Radiopharmaceutical Trials in Latin America: A Practical Logistics Playbook for Short‑Lived Isotopes

Radiopharmaceutical trials are a different operational species. The science may be the differentiator, but logistics is the constraint: short half-lives, radiation safety requirements, time-sensitive patient scheduling, and multi-agency approvals for cross-border movement. Sponsors who treat radiopharma like a conventional IMP supply chain often learn the hard way—through missed dosing windows and unusable shipments.

1) Start with the physics: half-life turns every delay into lost dose

If your isotope decays in hours, you don’t have “shipping delays”—you have immediate product shrinkage. The planning unit is not days; it is minutes. That means your protocol and operations plan must specify allowable time windows for production, release testing, transport, and administration, and it must include decision rules for when to cancel, reschedule, or reroute.

• Define the decay budget: the maximum elapsed time from end of synthesis to administration.
• Map critical control points: handoffs where delays occur (release, airport acceptance, customs, last-mile, site receiving).
• Build a “go/no-go” clock: so everyone knows when continuing becomes scientifically meaningless.

2) Cross-border execution in Latin America: permits, airports, and handoffs

In many Latin America routes, the main risk is not distance—it is variability: airline handling, airport screening queues, and country-by-country documentation requirements. The most reliable programs treat each shipment like a rehearsed procedure rather than an ad hoc package drop.

Internal execution experience across the region repeatedly highlights that reliability improves when sponsors standardize these elements:

• Packaging qualification: validated temperature/containment performance and clear labeling for every handler.
• Documentation kit: standardized set of shipping papers, permits, and emergency contacts—pre-reviewed by local experts.
• Chain of custody: timestamped handoffs with escalation triggers.
• Site receiving SOP: pre-briefed staff, equipment readiness, and immediate QC/receipt checks.

3) Site readiness: the hidden bottleneck

Even a perfect shipment fails if the site is not ready. A radiopharma site must coordinate pharmacy/nuclear medicine teams, imaging, patient prep, and administration windows. The sponsor’s job is to make this coordination easy and repeatable.

Recommended site readiness checklist:

• Weekly capacity confirmation: confirm patient slots, staff coverage, and scanner availability.
• Receiving drill: simulate the shipment arrival, handoff, and documentation review.
• Waste and incident plan: clear procedures for contamination, spills, and disposal aligned with local requirements.
• Back-up scheduling: a pre-identified alternative window when a shipment is delayed but still usable.

4) Resilience without runaway cost: design a tiered contingency plan

Not every shipment needs the most expensive option. Create a tiered plan:

• Tier 1 (default): primary carrier + primary route, with standard packaging and standard site workflow.
• Tier 2 (moderate disruption): alternate flight routings and a backup last-mile provider.
• Tier 3 (critical disruption): rapid escalation options, including premium routing and emergency re-release windows.

This structure helps you maintain reliability while containing cost—and it makes decision-making faster in the moment.

FAQ

Why is radiopharma logistics harder than standard drug trials?
Because many isotopes decay quickly, small delays in production, packaging, flight connections, or site preparation can reduce delivered activity and impact dosing windows.

What is the most common operational failure mode?
Misaligned schedules across cyclotron/production, export/import clearances, airport handling, last-mile transport, and site readiness—creating avoidable holds that consume half-life.

How do sponsors add resilience without exploding cost?
Use a tiered contingency plan: alternate flight routings, backup depots, standardized packaging, qualified second-source carriers, and rehearsed site receiving checklists; reserve higher-cost options only for critical shipments.

Need help executing radiopharma studies in Latin America? bioaccess® supports sponsors with regional operational planning, site activation support, and logistics coordination built for time-sensitive programs.